Table 2.
Item1 | Forward (5′–3′) | Reverse (5′–3′) |
---|---|---|
CLDN1 | GAAGATGCGGATGGCTGTCT | GGCCCGAGCCACTCTGTT |
CLDN2 | CCCTGACAGCACCAAATTTGA | GCAGGAGGCACAGAGGATGA |
CLDN3 | CGCGCTGCCCATGTG | GCTCTGCACCACGCAGTTC |
CLDN4 | GGAGGACGAGACAGCCAAAG | GTTGGCCGACCAGCAGAT |
OCLN | CATCGCCTCCATCGTCTACA | GTAGGCCTGGCTGCACATG |
TJP1 | ACAAAAACAGAGCTGAACAACTAGCTA | GCTACGCAAACCTCGGAATC |
MUC1 | CCTACCTGCCAGATACCATTGC | GAGAAGGGCTGGACTTGAGATG |
TNF-α | TATGTGCAGCAACCCGTAGTG | CTGACTCATAGCAGAGACGTGTCA |
IL-1β | ACCAACCCGACCAGGTCAA | ACATACGAGATGGAAACCAGCAA |
IL-6 | CGGCCTGTTCGCCTTTC | CAGGTGCTTTGTGCTGTAGCA |
CCL5 | CTGATACAACCGTGTGCTGCTT | GCTGCCTGTGGGCATTTG |
ACTB | AACACCCACACCCCTGTGAT | TGAGTCAAGCGCCAAAAGAA |
CLDN1, claudin-1; CLDN2, claudin-2; CLDN3, claudin-3; CLDN4, claudin-4; OCLN, occludin; TJP1, tight junction protein-1; MUC1, mucin-1; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; IL-6, interleukin-6; CCL5, C–C motif chemokine ligand-5; ACTB, β-actin.